13C-labeled indolequinone-DTPA-Gd conjugate for NMR probing cytochrome:P450 reductase-mediated one-electron reduction

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 2, 2011, Pages 790-793

  Komatsu, Hirokazu ^a   Tanabe, Kazuhito ^a   Nishimoto, Sei Ichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

13C NMR probe; Cytochrome:P450 reductase; Gd complex; Hypoxia; Paramagnetic effect

Indexed keywords

CYTOCHROME P450 REDUCTASE; GADOLINIUM; INDOLE DERIVATIVE; PENTETIC ACID;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONJUGATION; ENZYME ACTIVATION; HYPOXIA; ISOTOPE LABELING; MOLECULAR PROBE; REDUCTION; SYNTHESIS;

ANOXIA; CARBON ISOTOPES; ELECTRONS; GADOLINIUM DTPA; HUMANS; INDOLEQUINONES; NADPH-FERRIHEMOPROTEIN REDUCTASE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXIDATION-REDUCTION;

EID: 78651249337     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.11.105     Document Type: Article

References (33)

1. J.W.M. Cheng, W.H. Frishman, and W.S. Aronow Dm Disease-a-Month 56 2010 163
2. B.S. Masters, and C.C. Marohnic Drug Metab. Rev. 38 2006 209
3. K. Tanabe, Z. Zhang, T. Ito, H. Hatta, and S. Nishimoto Org. Biomol. Chem. 5 2007 3745
4. A.L. Harris Nat. Rev. Cancer 2 2002 38
5. P. Vaupel, F. Kallinowski, and P. Okunieff Cancer Res. 49 1989 6449
6. K. Tanabe, N. Hirata, H. Harada, M. Hiraoka, and S. Nishimoto ChemBioChem 9 2008 426
7. H. Komatsu, H. Harada, K. Tanabe, M. Hiraoka, and S. Nishimoto Med. Chem. Commun. 1 2010 50
8. K. Tanabe, H. Harada, M. Narazaki, K. Tanaka, K. Inafuku, H. Komatsu, T. Ito, H. Yamada, Y. Chujo, T. Matsuda, M. Hiraoka, and S. Nishimoto J. Am. Chem. Soc. 131 2009 15982
9. For recent reports on the molecular probe for hypoxia, see: E. Nakata, Y. Yukimachi, H. Kariyazono, S. Im, C. Abe, Y. Uto, H. Maezawa, T. Hashimoto, Y. Okamoto, and H. Hori Bioorg. Med. Chem. 17 2009 6952
10. W.P. Zhu, M. Dai, Y.F. Xu, and X.H. Qian Bioorg. Med. Chem. 16 2008 3255
11. Y. Liu, Y.F. Xu, X.H. Qian, Y. Xiao, J.W. Liu, L.Y. Shen, J.H. Li, and Y.X. Zhang Bioorg. Med. Chem. Lett. 16 2006 1562
12. Y. Liu, Y.F. Xu, X.H. Qian, J.W. Liu, L.Y. Shen, J.H. Li, and Y.X. Zhang Bioorg. Med. Chem. 14 2006 2935
13. R.J. Hodgkiss, R.W. Middleton, J. Parrick, H.K. Rami, P. Wardman, and G.D. Wilson J. Med. Chem. 35 1992 1920
14. R.J. Hodgkiss, G.W. Jones, A. Long, R.W. Middleton, J. Parrick, M.R.L. Stratford, P. Wardman, and G.D. Wilson J. Med. Chem. 34 1991 2268
15. S.J. Zhang, M. Hosaka, T. Yoshihara, K. Negishi, Y. Iida, S. Tobita, and T. Takeuchi Cancer Res. 70 2010 4490
16. K. Inomata, A. Ohno, H. Tochio, S. Isogai, T. Tenno, I. Nakase, T. Takeuchi, S. Futaki, Y. Ito, H. Hiroaki, and M. Shirakawa Nature 458 2009 106
17. T. Sakai, H. Tochio, T. Tenno, Y. Ito, T. Kokubo, H. Hiroaki, and M. Shirakawa J. Biomol. NMR 36 2006 179
18. S.E. Day, M.I. Kettunen, F.A. Gallagher, D.-E. Hu, M. Lerche, J. Wolber, K. Golman, J.H. Ardenkjaer-Larsen, and K.M. Brindle Nat. Med. 13 2007 1382
19. E. Boudreau, I. Pelczer, P.N. Borer, G.J. Heffron, and S.R. LaPlante Biophys. Chem. 109 2004 333
20. Y.J. Tang, H.G. Martin, S. Myersm, S. Rodriguez, E.E.K. Baidoo, and J.D. Keasling Mass Spectrom. Rev. 28 2009 362
21. J.P. Godin, L.B. Fay, and G. Hopfgartner Mass Spectrom. Rev. 26 2007 751
22. I.M. Lagoja, and P. Herdewijn Synth. Stuttgart 3 2002 301
23. B.P.B. Seriannias J. Biomol. Struct. Dyn. 11 1994 1133
24. J.M. Idee, M. Port, C. Robic, C. Medina, M. Sabatou, and C. Corot J. Magn. Reson. Imaging 30 2009 1249
25. S. Mizukami, R. Takikawa, Y. Sugihara, Y. Hori, H. Tochio, M. Wälchli, M. Shirakawa, and K. Kikuchi J. Am. Chem. Soc. 130 2008 794
26. M.A. Naylor, E. Swann, S.A. Everett, M. Jaffar, J. Nolan, N. Robertson, S.D. Lockyer, K.B. Patel, M.F. Dennis, M.R.L. Stratford, P. Wardman, G.E. Adams, C.J. Moody, and I.J. Stratford J. Med. Chem. 41 1998 2720
27. +] 634.2048, found 630.2048.
28. - 765.1) Purity was confirmed by analytical HPLC.
29. 13C-IQ-OH was conducted in a similar manner in the presence of MeCN (final concentration: 10%).
30. 13C-IQ-OH was distinctly observed in the NMR spectra as shown in Figure 3. This result strongly indicates that the catalytic reduction of indolequinone derivatives by CYP450 reductase occurred in the present system.
31. S. Ferrer, D.P. Naughton, and M.D. Threadgill Tetrahedron 59 2003 3445
32. M.A. Naylor, E. Swann, S.A. Everett, M. Jaffar, J. Nolan, N. Robertson, S.D. Lockyer, K.B. Patel, M.F. Dennis, M.R. Stratford, P. Wardman, G.E. Adams, C.J. Moody, and I.J. Stratford J. Med. Chem. 41 1998 2720
33. Bioreduction by other enzymes. Five enzymes (glucose dehydrogenase (from microorganism) PQQ-0.1 mg/mL, alcohol dehydrogenase (from yeast) 0.25 mg/mL, peroxidase (from horseradish) 0.1 mg/mL, nitrate reductase (cytochrome) 0.005 unit, and flavin reductase (recombinant) 1 μg/mL) were used in this study.